Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sara Hurvitz, MD
Jonsson Comprehensive Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Hematology Oncology Medical Group, Incorporated - Alhambra
Alhambra, California, United States
- Comprehensive Blood and Cancer Center
Bakersfield, California, United States
- St. Jude Heritage Medical Group at Virginia K. Crosson Cancer Center
Fullerton, California, United States
- North Valley Hematology-Oncology Medical Group
Northridge, California, United States
- Wilshire Oncology Medical Group, Incorporated - Pomona
Pomona, California, United States
- Sansum Medical Clinic
Santa Barbara, California, United States
- Central Coast Medical Oncology Corporation
Santa Maria, California, United States
- Santa Barbara Hematology Oncology - Solvang
Solvang, California, United States
- Cancer Care Associates Medical Group, Incorporated - Redondo Beach
Torrance, California, United States
- Cancer Institute of Florida, Pa - Orlando
Orlando, Florida, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Hematology and Oncology Consultants, Pa - Orlando
Orlando, Florida, United States
- Providence Medical Group
Haute Terre, Indiana, United States
- Comprehensive Cancer Centers of Nevada - Henderson
Henderson, Nevada, United States
- New Mexico Cancer Center
Albuquerque, New Mexico, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2009
- Primary completion
- 30 Nov 2013
- Completion
- —
- Last update posted
- 22 Jan 2016
- Registered enrollment
- 18
- Registry id
- NCT00769470
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.